Exenatide maintained glyceinic control with associated weight reduction over three years in patients with type 2 diabetes

被引：0
|
作者：
Buse, John
MacConell, Leigh
Stonehouse, Anthony
Guan, Xuesong
Malone, James
Okerson, Ted
Maggs, David
Kim, Dennis
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A73 / A74
页数：2
相关论文
共 50 条
  • [41] Weight Reduction Strategies for Patients with Type-2-Diabetes
    Blueher, M.
    [J]. DIABETOLOGE, 2017, 13 (02): : 123 - 136
  • [42] Effects of exenatide versus placebo on weight loss in patients with type 2 diabetes according to dietary
    Glass, L.
    Wolka, L.
    Guo, Y.
    Qu, Y.
    Bonnard, C.
    Salaun-Martin, C.
    [J]. DIABETES & METABOLISM, 2009, 35 : A8 - A9
  • [43] Free T4 is associated with exenatide-related weight loss in patients with type 2 diabetes mellitus and obesity
    Topaloglu, Omercan
    Toksoz, Didem Yildiz
    [J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (01) : 53 - 59
  • [44] Free T4 is associated with exenatide-related weight loss in patients with type 2 diabetes mellitus and obesity
    Ömercan Topaloğlu
    Didem Yıldız Toksöz
    [J]. International Journal of Diabetes in Developing Countries, 2024, 44 : 53 - 59
  • [45] Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetes
    Linnebjerg, H.
    Kothare, P. A.
    Seger, M.
    Wolka, A. M.
    Mitchell, M. I.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (02) : 99 - 108
  • [46] Effects of exenatide on metabolic parameters/control in obese Japanese patients with type 2 diabetes
    Tokuda, Masaru
    Katsuno, Tomoyuki
    Ochi, Fumihiro
    Miyakoshi, Kana
    Kusunoki, Yoshiki
    Murai, Kazuki
    Miuchi, Masayuki
    Hamaguchi, Tomoya
    Miyagawa, Jun-ichiro
    Namba, Mitsuyoshi
    [J]. ENDOCRINE JOURNAL, 2014, 61 (04) : 365 - 372
  • [47] Effects of exenatide on glycemic control, weight, lipid and blood pressure in 129 patients with type 2 diabetes: predictors of good response
    Lemaitre-Brame, L.
    Rouget, J. P.
    Delecourt, F.
    Jeanjean, M. E.
    Merlen, E.
    Vambergue, A.
    Fontaine, P.
    [J]. DIABETES & METABOLISM, 2012, 38 : A104 - A104
  • [48] Usefulness of Exenatide Therapy in Patients With Type 2 Diabetes Under Undesirable Glycemic Control
    Yoshida, Mami
    Yamamoto, Naomune
    Saeki, Akio
    Sugino, Masakazu
    Yoshida, Shigeru
    Kuzuya, Takeshi
    Ohsawa, Nakaaki
    Hanafusa, Toshiaki
    [J]. DIABETES, 2012, 61 : A619 - A619
  • [49] Exenatide maintains glycemic control for 2 years in patients with type 2 diabetes: data from an ongoing, open-label study
    Ratner, RE
    Stonehouse, A
    Gao, HY
    Poon, T
    Kim, D
    [J]. DIABETOLOGIA, 2005, 48 : A288 - A289
  • [50] The role of education and weight reduction in control of Type 2 diabetes.
    Nikousokhan, AK
    Rajab, A
    [J]. DIABETOLOGIA, 2003, 46 : A87 - A87
12345